SCHEDULE: ClearPoint Neuro: Bigger Capital, Michael Bigger Disclose Stakes

Bigger Capital Fund LP, District 2 Capital Fund LP, and Michael Bigger have disclosed their beneficial ownership in ClearPoint Neuro, Inc., with Michael Bigger holding a 7.7% stake.

Summary

• Bigger Capital Fund LP and its general partner, Bigger Capital Fund GP, LLC, beneficially own 1,166,372 shares of ClearPoint Neuro, Inc. Common Stock, representing approximately 4.2% of the outstanding shares.
• District 2 Capital Fund LP, along with its related entities District 2 Capital LP, District 2 GP LLC, and District 2 Holdings LLC, beneficially own 430,174 shares, representing approximately 1.5% of the outstanding shares.
• Michael Bigger, as managing member of Bigger Capital Fund GP, LLC and District 2 Holdings LLC, beneficially owns an aggregate of 2,142,238 shares, which includes shares held by Bigger Capital, District 2 CF, his spouse Patricia Winter (167,000 shares), his sons (338,000 shares), and his IRA account (40,692 shares), totaling approximately 7.7% of the outstanding shares.
• Patricia Winter beneficially owns 167,000 shares, representing 0% of the outstanding shares.
• The percentages are based on 27,989,194 shares of Common Stock outstanding as of May 7, 2025.

Sentiment

Score: 5

Explanation: The filing is a neutral disclosure of beneficial ownership, providing transparency without indicating positive or negative operational or financial developments.

Positives

• Increased transparency regarding significant shareholder stakes.
• The combined stake of Michael Bigger and related entities indicates a notable investor interest in ClearPoint Neuro, Inc.

Risks

• The securities were not acquired or held for the purpose of changing or influencing control of the issuer, which mitigates potential risks associated with activist investor actions.

Industry Context

This filing is a routine disclosure of significant ownership stakes in a publicly traded company, common across all industries. It does not provide specific industry-related insights beyond identifying the company as ClearPoint Neuro, Inc., which operates in the medical technology or neuroscience sector.

Related Party Transactions

• Michael Bigger's reported beneficial ownership includes shares held by his spouse, Patricia Winter (167,000 shares), and his sons (338,000 shares).

Stakeholder Impact

• Shareholders gain transparency regarding significant institutional and individual ownership stakes in the company.
• The disclosure of a 7.7% stake by Michael Bigger and related entities could influence investor perception of the stock's stability or potential for future engagement, despite the disclaimer of control intent.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership and does not contain financial performance data, strategic updates, or other information typically used to formulate a 'buy' or 'sell' recommendation. The significant stake held by Michael Bigger and associated entities, while notable, is explicitly stated not to be for the purpose of changing or influencing control, suggesting a passive investment stance. Therefore, a 'hold' recommendation is appropriate as there are no new catalysts or red flags presented in this specific filing to alter an existing investment thesis.

Keywords

ClearPoint Neuro, CPT, SEC filing, Schedule 13G, beneficial ownership, institutional ownership, Michael Bigger, Bigger Capital, District 2 Capital, common stock, investment